Detalles de la búsqueda
1.
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy.
Gut
; 73(3): 496-508, 2024 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37758326
2.
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial.
Lancet Oncol
; 21(3): 398-411, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32014119
3.
Development and validation of a model to predict outcomes of colon cancer surveillance.
Cancer Causes Control
; 30(7): 767-778, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31129907
4.
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study.
Br J Cancer
; 115(4): 420-4, 2016 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27434036
5.
Site and Stage of Colorectal Cancer Influence the Likelihood and Distribution of Disease Recurrence and Postrecurrence Survival: Data From the FACS Randomized Controlled Trial.
Ann Surg
; 263(6): 1143-7, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26135689
6.
Hepatic metastases resection after cetuximab: are we missing something? - Authors' reply.
Lancet Oncol
; 21(5): e229, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32359494
7.
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial.
Lancet Oncol
; 15(6): 601-11, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24717919
8.
T cells but not NK cells are associated with a favourable outcome for resected colorectal liver metastases.
BMC Cancer
; 14: 180, 2014 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24625075
9.
Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial.
J Clin Oncol
; 42(15): 1799-1809, 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38640453
10.
Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial.
JAMA Oncol
; 9(9): 1245-1254, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37471075
11.
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy.
NPJ Precis Oncol
; 6(1): 72, 2022 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36241710
12.
Laparoscopic versus open resections in the posterosuperior liver segments within an enhanced recovery programme (ORANGE Segments): study protocol for a multicentre randomised controlled trial.
Trials
; 23(1): 206, 2022 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35264216
13.
Intratumoural immune signature to identify patients with primary colorectal cancer who do not require follow-up after resection: an observational study.
Health Technol Assess
; 25(2): 1-32, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33416473
14.
Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis.
Eur J Cancer
; 144: 368-381, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33422803
15.
Population-based observational study of acute pancreatitis in southern England.
Ann R Coll Surg Engl
; 101(7): 487-494, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31362520
16.
Long non-coding RNAs within the tumour microenvironment and their role in tumour-stroma cross-talk.
Cancer Lett
; 421: 94-102, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29458141
17.
The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.
PLoS One
; 12(3): e0171810, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28282381
18.
What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial.
Health Technol Assess
; 21(22): 1-60, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28617240
19.
Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial.
Oncotarget
; 8(55): 93856-93866, 2017 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29212194
20.
A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
Health Technol Assess
; 21(32): 1-86, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28641703